Dr. Karsten Fischer
BioMedPartners
BOD
Redpoint Research
Singapore
Biography
Dr. Karsten Fischer joined BioMedPartners AG in October 2012 with a track record in investment banking, pharmaceuticals, management consulting, and venture capital within the life science sector. Previously, Dr. Fischer has been working for WestLB in the healthcare and chemicals sector where he was heading the equity capital markets team. Before that, he gained experience at Sanofi, McKinsey & Company, and Deutsche Venture Capital.He holds a PhD in infection biology (MPI Infection Biology and Colorado State University).
Research Interest
infection biology, Finance